HSDT Stock, Helius Medical Technologies Inc. Information

Helius Medical Technologies Inc., is engaged primarily in the medical technology industry focused on neurological wellness. The Company s planned principal operations include the development, licensing and acquisition of unique and non invasive platform technologies to amplify the brain s ability to heal itself. The Company s first product in development, known as the portable neuromodulation stimulator or PoNS therapy platform, is designed to enhance the brain s ability to compensate for this damage. The PoNS therapy is a combination of a powerful, wearable, direct current stimulation device, and functional, targeted therapy, and is currently being developed for the treatment of movement, gait and balance disorders in patients with traumatic brain injury and other chronic neurological diseases